Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.

Marsh RA, Leiding JW, Logan BR, Griffith LM, Arnold DE, Haddad E, Falcone EL, Yin Z, Patel K, Arbuckle E, Bleesing JJ, Sullivan KE, Heimall J, Burroughs LM, Skoda-Smith S, Chandrakasan S, Yu LC, Oshrine BR, Cuvelier GDE, Thakar MS, Chen K, Teira P, Shenoy S, Phelan R, Forbes LR, Chellapandian D, Dávila Saldaña BJ, Shah AJ, Weinacht KG, Joshi A, Boulad F, Quigg TC, Dvorak CC, Grossman D, Torgerson T, Graham P, Prasad V, Knutsen A, Chong H, Miller H, de la Morena MT, DeSantes K, Cowan MJ, Notarangelo LD, Kohn DB, Stenger E, Pai SY, Routes JM, Puck JM, Kapoor N, Pulsipher MA, Malech HL, Parikh S, Kang EM; submitted on behalf of the Primary Immune Deficiency Treatment Consortium.

J Clin Immunol. 2019 Oct;39(7):653-667. doi: 10.1007/s10875-019-00659-8. Epub 2019 Aug 2.

PMID:
31376032
2.

Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.

Cuvelier GDE, Nemecek ER, Wahlstrom JT, Kitko CL, Lewis VA, Schechter T, Jacobsohn DA, Harris AC, Pulsipher MA, Bittencourt H, Choi SW, Caywood EH, Kasow KA, Bhatia M, Oshrine BR, Flower A, Chaudhury S, Coulter D, Chewning JH, Joyce M, Savaşan S, Pawlowska AB, Megason GC, Mitchell D, Cheerva AC, Lawitschka A, West LJ, Pan B, Al Hamarneh YN, Halevy A, Schultz KR.

Blood. 2019 Jul 18;134(3):304-316. doi: 10.1182/blood.2019000216. Epub 2019 May 1.

PMID:
31043425
3.

Access to Hematopoietic Stem Cell Transplantation among Pediatric Patients with Acute Lymphoblastic Leukemia: A Population-Based Analysis.

Truong TH, Pole JD, Bittencourt H, Schechter T, Cuvelier GDE, Paulson K, Rayar M, Mitchell D, Schultz KR, O'Shea D, Barber R, Wall D, Sung L.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1172-1178. doi: 10.1016/j.bbmt.2019.02.009. Epub 2019 Feb 12.

PMID:
30769192
4.

Clinical presentation, immunologic features, and hematopoietic stem cell transplant outcomes for IKBKB immune deficiency.

Cuvelier GDE, Rubin TS, Junker A, Sinha R, Rosenberg AM, Wall DA, Schroeder ML.

Clin Immunol. 2019 Aug;205:138-147. doi: 10.1016/j.clim.2018.10.019. Epub 2018 Oct 31.

PMID:
30391351
5.

Newborn Screening for IKBKB Deficiency in Manitoba, Using Genetic Mutation Analysis.

Rubin TS, Rockman-Greenberg C, Van Caeseele P, Cuvelier GDE, Kwan L, Schroeder ML.

J Clin Immunol. 2018 Oct;38(7):742-744. doi: 10.1007/s10875-018-0555-2. Epub 2018 Oct 4. No abstract available.

PMID:
30288645
6.

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.

Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, Small TN, Chaisson J, Dvorak CC, Murnane M, Kapoor N, Abdel-Azim H, Hanson IC, Martinez C, Bleesing JJH, Chandra S, Smith AR, Cavanaugh ME, Jyonouchi S, Sullivan KE, Burroughs L, Skoda-Smith S, Haight AE, Tumlin AG, Quigg TC, Taylor C, Dávila Saldaña BJ, Keller MD, Seroogy CM, Desantes KB, Petrovic A, Leiding JW, Shyr DC, Decaluwe H, Teira P, Gillio AP, Knutsen AP, Moore TB, Kletzel M, Craddock JA, Aquino V, Davis JH, Yu LC, Cuvelier GDE, Bednarski JJ, Goldman FD, Kang EM, Shereck E, Porteus MH, Connelly JA, Fleisher TA, Malech HL, Shearer WT, Szabolcs P, Thakar MS, Vander Lugt MT, Heimall J, Yin Z, Pulsipher MA, Pai SY, Kohn DB, Puck JM, Cowan MJ, O'Reilly RJ, Notarangelo LD.

Blood. 2018 Oct 25;132(17):1737-1749. doi: 10.1182/blood-2018-03-840702. Epub 2018 Aug 28.

7.

The clinical impact of copy number variants in inherited bone marrow failure syndromes.

Waespe N, Dhanraj S, Wahala M, Tsangaris E, Enbar T, Zlateska B, Li H, Klaassen RJ, Fernandez CV, Cuvelier GDE, Wu JK, Pastore YD, Silva M, Lipton JH, Brossard J, Michon B, Abish S, Steele M, Sinha R, Belletrutti MJ, Breakey VR, Jardine L, Goodyear L, Kofler L, Cada M, Sung L, Shago M, Scherer SW, Dror Y.

NPJ Genom Med. 2017 May 10;2. pii: 18. doi: 10.1038/s41525-017-0019-2.

8.

Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.

McMahon KR, Rod Rassekh S, Schultz KR, Pinsk M, Blydt-Hansen T, Mammen C, Tsuyuki RT, Devarajan P, Cuvelier GD, Mitchell LG, Baruchel S, Palijan A, Carleton BC, Ross CJ, Zappitelli M; Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Group.

Can J Kidney Health Dis. 2017 Feb 16;4:2054358117690338. doi: 10.1177/2054358117690338. eCollection 2017.

9.

Transplantation-associated thrombotic microangiopathy isolated to a congenital anomaly of the lung.

Kummen RT, Cuvelier GD, Stefanovici C, Perry AM, Higgins R, Yanofsky R, Lum Min SA, Wall DA.

Pediatr Transplant. 2017 Feb;21(1). doi: 10.1111/petr.12824. Epub 2016 Nov 24.

PMID:
27882637
10.

Aggressive Metastatic Inflammatory Myofibroblastic Tumor After Allogeneic Stem Cell Transplant With Fatal Pulmonary Toxicity From Crizotinib.

Shash H, Stefanovici C, Phillips S, Cuvelier GD.

J Pediatr Hematol Oncol. 2016 Nov;38(8):642-645.

PMID:
27271810
11.

Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.

Bartelink IH, Lalmohamed A, van Reij EM, Dvorak CC, Savic RM, Zwaveling J, Bredius RG, Egberts AC, Bierings M, Kletzel M, Shaw PJ, Nath CE, Hempel G, Ansari M, Krajinovic M, Théorêt Y, Duval M, Keizer RJ, Bittencourt H, Hassan M, Güngör T, Wynn RF, Veys P, Cuvelier GD, Marktel S, Chiesa R, Cowan MJ, Slatter MA, Stricherz MK, Jennissen C, Long-Boyle JR, Boelens JJ.

Lancet Haematol. 2016 Nov;3(11):e526-e536. doi: 10.1016/S2352-3026(16)30114-4. Epub 2016 Oct 13.

12.

Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.

Cuvelier GD, Rubin TS, Wall DA, Schroeder ML.

J Clin Immunol. 2016 Oct;36(7):713-24. doi: 10.1007/s10875-016-0316-z. Epub 2016 Jul 20.

PMID:
27438785
13.

Accrual of adolescents and young adults with cancer to clinical trials.

Hay AE, Rae C, Fraser GA, Meyer RM, Abbott LS, Bevan S, McBride ML, Cuvelier GD, McKillop S, Barr RD.

Curr Oncol. 2016 Apr;23(2):e81-5. doi: 10.3747/co.23.2925. Epub 2016 Apr 13. No abstract available.

14.

Functional Myeloid-Derived Suppressor Cell Subsets Recover Rapidly after Allogeneic Hematopoietic Stem/Progenitor Cell Transplantation.

Guan Q, Blankstein AR, Anjos K, Synova O, Tulloch M, Giftakis A, Yang B, Lambert P, Peng Z, Cuvelier GD, Wall DA.

Biol Blood Marrow Transplant. 2015 Jul;21(7):1205-14. doi: 10.1016/j.bbmt.2015.04.015. Epub 2015 May 9.

15.

Toxic epidermal necrolysis and hemophagocytic lymphohistiocytosis: a case report and literature review.

Sniderman JD, Cuvelier GD, Veroukis S, Hansen G.

Clin Case Rep. 2015 Feb;3(2):121-5. doi: 10.1002/ccr3.170. Epub 2014 Nov 17.

16.

Cancer incidence, morbidity, and survival in Canadian first nation children: a Manitoba population-based study from the cancer in young people in Canada (CYP-C) registry.

Stammers DM, Israels SJ, Lambert PJ, Cuvelier GD.

Pediatr Blood Cancer. 2014 Dec;61(12):2164-9. doi: 10.1002/pbc.25005. Epub 2014 Feb 26.

PMID:
24616082
17.

A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.

Cuvelier GD, Baker TJ, Peddie EF, Casey LM, Lambert PJ, Distefano DS, Wardle MG, Mychajlunow BA, Romanick MA, Dix DB, Wilson BA.

Pediatr Blood Cancer. 2014 Apr;61(4):672-9. doi: 10.1002/pbc.24828. Epub 2013 Oct 26.

PMID:
24167059
18.

Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation.

Savic RM, Cowan MJ, Dvorak CC, Pai SY, Pereira L, Bartelink IH, Boelens JJ, Bredius RG, Wynn RF, Cuvelier GD, Shaw PJ, Slatter MA, Long-Boyle J.

Biol Blood Marrow Transplant. 2013 Nov;19(11):1608-14. doi: 10.1016/j.bbmt.2013.08.014. Epub 2013 Sep 9.

19.

Predictive performance of a busulfan pharmacokinetic model in children and young adults.

Bartelink IH, van Kesteren C, Boelens JJ, Egberts TC, Bierings MB, Cuvelier GD, Wynn RF, Slatter MA, Chiesa R, Danhof M, Knibbe CA.

Ther Drug Monit. 2012 Oct;34(5):574-83.

PMID:
22972539
20.

Publication bias is present in blood and marrow transplantation: an analysis of abstracts at an international meeting.

Paulson K, Saeed M, Mills J, Cuvelier GD, Kumar R, Raymond C, Robinson T, Szwajcer D, Wall D, Seftel MD.

Blood. 2011 Dec 15;118(25):6698-701. doi: 10.1182/blood-2011-08-367466. Epub 2011 Oct 28.

PMID:
22039259
21.

Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.

Cuvelier GD, Kariminia A, Fujii H, Aslanian S, Wall D, Goldman F, Grupp SA, Dunn SE, Krailo M, Shapiro LH, Gilman A, Schultz KR.

Bone Marrow Transplant. 2010 Nov;45(11):1653-7. doi: 10.1038/bmt.2010.15. Epub 2010 Mar 1.

22.

Optimizing outcomes of hematopoietic stem cell transplantation for severe combined immunodeficiency.

Cuvelier GD, Schultz KR, Davis J, Hirschfeld AF, Junker AK, Tan R, Turvey SE.

Clin Immunol. 2009 May;131(2):179-88. doi: 10.1016/j.clim.2009.01.003. Epub 2009 Feb 13. Review.

PMID:
19217351
24.

Torticollis as a sign of cervico-thoracic epidural haematoma in an infant with severe haemophilia A.

Cuvelier GD, Davis JH, Purves EC, Wu JK.

Haemophilia. 2006 Nov;12(6):683-6.

PMID:
17083523

Supplemental Content

Loading ...
Support Center